Covid 19 will disappear, we have Remdesivir rememb
Post# of 148341
That the FDA negligently avoided seeking advisory committee input is documented by the fact that prior to approving remdesivir,the agency had reviewed an October 15, 2020, preprint article that presented interim results of the World Health Organization (WHO)Solidarity trial, which was subsequently published in the New England Journal of Medicine online on December 2 and in print on February11.2 That large, multicenter, randomized clinical trial seriously challenged the FDA’s conclusion that remdesivir is effective as a treatment for COVID-19.The WHO Solidarity trial investigators concluded,“Remdesivir...appeared to have little or no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation and duration of hospital stay.